Unknown

Dataset Information

0

Expression of immune checkpoints (IDO and PD-L1) in oral tongue cancer patients: a 10-year retrospective cohort study in Pakistan

ABSTRACT:

SUBMITTER: Fatima M 

PROVIDER: S-EPMC12378751 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma.
| S-EPMC11343147 | biostudies-literature
Unknown The aryl hydrocarbon receptor controls IFN-γ-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma.
| S-EPMC12213245 | biostudies-literature
Unknown Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer.
| S-EPMC8178863 | biostudies-literature
Unknown Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4.
| S-EPMC8952773 | biostudies-literature
Unknown IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
| S-EPMC4791231 | biostudies-literature
Unknown Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.
| S-EPMC12824258 | biostudies-literature
Unknown High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
| S-EPMC7918978 | biostudies-literature
Unknown Prognostic value of human papilloma virus (HPV) status and programmed cell death ligand 1 (PD-L1) status in oral tongue cancer.
| S-EPMC11809567 | biostudies-literature
Unknown Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.
| S-EPMC8077906 | biostudies-literature
Unknown PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies.
| S-EPMC7914151 | biostudies-literature